Medtronic Q1 FY27 organic revenue growth 13.7%; raises FY27 guidance
MDT reported Q1 FY27 organic revenue growth of 13.7% to $9.8B and adjusted EPS of $1.45. The company raised full-year FY27 guidance for both revenue and EPS, citing strong execution and innovation.
Q1 FY27 saw 13.7% organic revenue growth to $9.8B and adjusted EPS of $1.45, with broad-based strength across major business units and significant contributions from CAS, Altaviva, and robotics.
FY27 guidance was raised for both revenue and EPS, supported by strong execution and innovation.Based on…